PainReform

2.07
开盘价
2.09
市值
1.78M+
最高价
2.12
最低价
2.04
收盘价
2.10
成交量
6.56K+
市盈率
-0.01
股息率
0.00%

PainReform简介

派恩改革有限公司是一家制药公司,专注于对已有的疗法进行重新配方。它提供PRF-110,这是一种油基、粘性、透明的溶液,在闭合前直接沉积到手术伤口床中,提供局部和延长的术后止痛。该公司由Lihu Avitov和Dan Teleman于2007年创立,总部设在以色列赫兹利亚。

如何购买 PainReform (PRFX)

登录
1分钟开户

1分钟开户

仅需1分钟即可完成账户申请和验证。整个过程完全自助,支持 RockFlow App 和网页端操作。

充值资金

充值资金

账户验证完成后,您可以使用首选的支付方式向账户充值。

购买 PRFX

购买 PRFX

通过 RockFlow App 或网页端搜索 PRFX,输入您想要投资的金额,然后点击确认即可完成交易。

logo

Social

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.